Primary Objectives:
1. To determine the feasibility and toxicity profile of administering liposomal
9-Nitro-20-(S)-Camptothecin (L9-NC) by aerosol alone and in combination with
temozolomide.
2. To determine the effectiveness of L9-NC given by aerosol in combination with
temozolomide in patients with solid tumors involving the lungs.